@misc{Gołąb_Jakub_Immunomodulatory_2001,
 author={Gołąb, Jakub and Zagożdżon, Radosław},
 volume={54},
 number={3},
 copyright={Creative Commons Attribution BY-SA 4.0 license},
 journal={Biotechnologia, vol.54, 3 (2001)-.},
 howpublished={online},
 year={2001},
 publisher={Committee on Biotechnology PAS},
 publisher={Institute of Bioorganic Chemistry PAS},
 language={pol},
 abstract={Chemotherapeutics are still regarded as a mainstay of antitumor strategies.A number of observations indicate that these agents might be used at low doseswith the same or even better efficacy than the high-dose chemotherapy. The efficacy of the low-dose chemotherapy might be at least partly explained by theregulation of the antitumor immune response. These immunomodulatory effects might be further potentiated by combinations with selected biological response modifiers, such as recombinant cytokines (lL-2, TNF, IL-12). The effectiveness of such combinations has already proved encouraging in pre-clinicalmodels.},
 title={Immunomodulatory effects of selected chemotherapeutics},
 type={Text},
 URL={http://www.rcin.org.pl/Content/138860/PDF/POZN271_174149_biotechnologia-2001-no3-go%C5%82%C4%85b.pdf},
 keywords={biotechnology},
}